We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+9.69%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$5.51B
AUM Growth
+$445M
Cap. Flow
-$338M
Cap. Flow %
-6.13%
Top 10 Hldgs %
54.24%
Holding
167
New
43
Increased
28
Reduced
13
Closed
43

Top Buys

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$79.3M
2
MRK icon
Merck
MRK
+$68.2M
3
VERA icon
Vera Therapeutics
VERA
+$51.7M
4
LEGN icon
Legend Biotech
LEGN
+$39.5M
5
CNC icon
Centene
CNC
+$30.1M

Sector Composition

Rank Sector Weight
1 Healthcare 89.05%
2 Real Estate 0.41%
3 Financials 0%
4 Industrials 0%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CERS icon
126
Cerus
CERS
$587M
-44,693
Closed -$62.1K
CGON icon
127
CG Oncology
CGON
$6.11B
-850,695
Closed -$20.8M
DHC
128
Diversified Healthcare Trust
DHC
$2.26B
-33,892
Closed -$81.3K
DVAX
129
DELISTED
Dynavax Technologies
DVAX
-5,191,493
Closed -$67.3M
DXC icon
130
DXC Technology
DXC
$1.63B
-11,883
Closed -$203K
DYN icon
131
Dyne Therapeutics
DYN
$4.04B
-812,408
Closed -$8.5M
ESTA icon
132
PUT
Establishment Labs
ESTA
$2.72B
-500,000
Closed -$20.4M
FPI
133
Farmland Partners
FPI
$419M
-16,863
Closed -$188K
GHRS icon
134
GH Research
GHRS
$1.87B
-925,000
Closed -$10.2M
HNRG icon
135
Hallador Energy
HNRG
$718M
-13,713
Closed -$168K
INMD icon
136
InMode
INMD
$872M
-1,578,708
Closed -$28M
JOE icon
137
St. Joe Company
JOE
$3.57B
-4,473
Closed -$210K
LNTH icon
138
Lantheus
LNTH
$6.82B
-240,218
Closed -$23.4M
MAX icon
139
MediaAlpha
MAX
$710M
-10,795
Closed -$99.7K
MFA
140
MFA Financial
MFA
$929M
-10,935
Closed -$112K
MNKD icon
141
MannKind Corp
MNKD
$1.28B
-17,380
Closed -$87.4K
MXCT icon
142
MaxCyte
MXCT
$116M
-19,121
Closed -$52.2K
NGNE icon
143
Neurogene
NGNE
$696M
-446,880
Closed -$5.23M
NUVB icon
144
Nuvation Bio
NUVB
$2.24B
-45,448
Closed -$80K
OLPX
145
DELISTED
Olaplex Holdings
OLPX
-28,833
Closed -$36.6K
OPK icon
146
Opko Health
OPK
$921M
-6,906,362
Closed -$11.5M
QTRX icon
147
Quanterix
QTRX
$173M
-11,023
Closed -$71.8K
REI icon
148
Ring Energy
REI
$322M
-127,376
Closed -$146K
RPAY icon
149
Repay Holdings
RPAY
$315M
-13,175
Closed -$73.4K
RUN icon
150
Sunrun
RUN
$2.37B
-10,124
Closed -$59.3K

Similar funds

Deerfield Management's Q2 2025 Portfolio in Review

As of Q2 2025, Deerfield Management held 167 positions worth $5.51B, up 8.8% from $5.06B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Deerfield Management withdrew a net $338M in Q2 2025, closing 43 positions and reducing 13 holdings. Its most notable exit was Dynavax Technologies, an estimated $67.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 87% a quarter earlier, followed by Real Estate and Financials.

Against the trend, Deerfield Management opened a new position in Merck worth $67.9M.

  • Deerfield Management's largest Q2 2025 buy was Merck: 857,724 shares worth $67.9M.
  • Deerfield Management added most to United Therapeutics in Q2 2025, an estimated $79.3M increase.
  • Deerfield Management's biggest Q2 2025 reduction was Alignment Healthcare, cutting an estimated $68M.
  • Deerfield Management fully exited Dynavax Technologies in Q2 2025, selling an estimated $67.3M.
  • Deerfield Management's ten largest holdings make up 54% of its $5.51B portfolio in Q2 2025.
  • Deerfield Management opened 43 new positions and closed 43 in Q2 2025.
  • Deerfield Management's portfolio value rose 8.8% quarter-over-quarter to $5.51B.

Based on Deerfield Management's 13F filing for Q2 2025, filed 14 Aug 2025.